Improved detection of hepatitis C virus-positive blood donors and determination of infection status

Transfus Med. 2023 Apr;33(2):159-164. doi: 10.1111/tme.12930. Epub 2022 Oct 17.

Abstract

Background: In low-risk populations, variability in the sensitivity of current serological tests for Hepatitis C virus (HCV) blood donor screening may lead to the presence of false-positive results. This contributes to the unnecessary loss of blood donor samples as well as to difficulty in accurate donor counselling. The present study determined the optimal cut-off value of a chemiluminescent immunoassay for identification of HCV-reactive blood donors.

Study design and methods: In a retrospective cross-sectional analysis of 193 973 blood donations, 578 samples that were positive for HCV antibody in a chemiluminescent immunoassay and/or RNA screening tests were identified. Blood from 379 of these positive samples was available for retesting by a second confirmatory HCV immunoassay followed by a receiver operating characteristic (ROC) curve analysis. Donors were also recalled for a new analysis.

Results: Only 71 (18.7%) blood samples remained HCV-positive upon retesting, while 233 (61.5%) now tested negative and 75 (19.8%) yielding indeterminate results. A signal to cutoff ratio ≥4.32 was determined as the best differential threshold between a positive and negative result, increasing the positive predictive value from 27.3% to 66.7%.

Conclusion: Using a higher threshold for an HCV-positive blood sample enhances the chemiluminescent immunoassay screening test´s accuracy and helps to improve donor counselling and notification processes.

Keywords: blood donors; chemiluminescent immunoassay; hepatitis C virus detection; signal-to-cutoff ratio.

MeSH terms

  • Blood Donors*
  • Cross-Sectional Studies
  • Hepacivirus
  • Hepatitis C Antibodies
  • Hepatitis C* / diagnosis
  • Humans
  • Retrospective Studies

Substances

  • Hepatitis C Antibodies